Premium
The prevalence of loss of heterozygosity in chromosome 3, including FHIT , in bladder cancer, using the fluorescent multiplex polymerase chain reaction
Author(s) -
Wada T.,
Louhelainen J.,
Hemminki K.,
Adolfsson J.,
Wijkström H.,
Norming U.,
Borgström E.,
Hansson J.,
Steineck G.
Publication year - 2001
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1046/j.1464-410x.2001.02212.x
Subject(s) - loss of heterozygosity , locus (genetics) , biology , multiplex polymerase chain reaction , bladder cancer , fhit , polymerase chain reaction , chromosome , carcinoma , pathology , population , microbiology and biotechnology , cancer research , gene , cancer , tumor suppressor gene , genetics , carcinogenesis , medicine , allele , environmental health
Objective To determine some of the genetic alterations involved in the pathogenesis and progression of transitional cell carcinoma of the bladder. Materials and methods In a population‐based study, freshly frozen tissue was collected from all patients newly diagnosed with urinary bladder cancer in the Stockholm region during 1995–1996. The prevalence of loss of heterozygosity (LOH) was assessed at seven sites on chromosome 3, analysed in 151 patients, using a fluorescent multiplex polymerase chain reaction based on DNA from the tumour and peripheral blood. Results LOH was detected in 12.1% (at 3q25–26.2) to 22.1% (at 3p11–12) of the informative cases. Relatively frequent LOH was detected at 3p22–24.2 (21.6%), at 3p14.2 within FHIT (21.5%), and at 3p11–12 (22.1%). Of 151 tumours, 72 (47.7%) showed LOH at one or more loci on chromosome 3. LOH on chromosome 3 was weakly associated with tumour grade ( P = 0.095), but not with tumour stage ( P = 0.701). However, when the frequency of LOH was analysed individually at each site, the prevalence of LOH at 3p11–12 was closely correlated with higher tumour stage ( P = 0.011). Replication errors were detected in only four of 151 (2.6%) tumours. Conclusion These findings suggest that the 3p11–12 locus may involve a putative candidate tumour‐suppressor gene which might be associated with bladder tumour invasiveness. The FHIT gene locus showed a relatively high frequency of LOH even in Ta tumours.